Mindpeak's PD-L1: First AI to be used in labs in Belgium to fight cancer
Ziekenhuis Netwerk Antwerpen (ZNA) and GZA Hospitals chose Mindpeak’s PD-L1 AI to become the first lab in Belgium to use artificial intelligence in the fight against cancer.
Deeply integrated into the Telemis-platform, our AI helps their pathologists diagnose patients quicker and more reproducible by considering the complete tissue on images from biopsies and resectates - especially from the lung (PD-L1).
"With our AI, the matching of cancer patients to drugs can be significantly improved in clinical routine, which in turn greatly increases the chances of cure," says our founder and CEO Felix Faber.
Find out more about our AI-based diagnostics
Company information
Local court Hamburg HRB 151143
Managing director:
Felix Faber
V.A.T. identification number:
DE318495606
Founded in 2018
.webp)
© 2024 Mindpeak GmbH
Supported by:
